Perimenopause Age: When It Starts, When Symptoms Peak, and When It Ends

Quick answer: Perimenopause usually starts in the mid- to late 40s. The two large US cohorts that measured the start directly put the median near 47 — 47.5 years in the Massachusetts Women's Health Study (McKinlay et al., 1992), and adjusted medians of 47.27 years for non-smokers and 46.05 for current smokers in SWAN (Paramsothy et al., 2017). Onset as early as the mid-30s and as late as the mid-50s is also documented, and no age on that scale is diagnostic on its own.

Three different ages get compressed into that one number, and the compression is where most of the confusion starts. When the transition begins, when symptoms are at their worst, and when it is actually over are three separate measurements with three separate answers, and they are years apart. Which number you want depends on which question you are really asking.

The three ages that get mixed up

Read down that table and the spread is the point. The age at which this begins and the age at which it is worst are separated by five or six years for a typical woman, which is why "what age is perimenopause" has never had a single honest answer.

Why the final period is given as 51 in some places and 52 in others

Both numbers are in wide circulation, and the split does not follow any tidy rule — it is not US against UK, or government agency against professional society.

US federal sources give 52: "the average age of menopause is 52 in the United States" (NIA), and the Office on Women's Health says the same while adding a usual range of 45 to 58 (OWH). The Menopause Society agrees, and draws out the consequence most pages skip: "because the average age of menopause is 52 years, about half of women will not have reached menopause by this age," with about 90% having reached it by 55 (The Menopause Society).

Three equally mainstream sources give 51: "The average age that women go through menopause is 51 years" (ACOG); "In the United States, the average age of physiologic menopause is 51 years old" (Merck Manual); "In the UK, the average age for a woman to reach menopause is 51" (NHS inform).

SWAN shows how both can be defensible, because the figure moves with the study design. Its 1995–1997 cross-sectional analysis of 14,620 women gave an adjusted median of 51.4 years (Gold et al., 2001). Its longitudinal analysis, following 3,302 women to 1,483 observed natural final periods between 1996 and 2007, gave 52.54 years (Gold et al., 2013). The Massachusetts cohort landed at 51.3 (McKinlay et al., 1992). A year of spread between designs is the normal width of this estimate rather than a contradiction, and nothing you would decide differently falls inside it.

When symptoms peak, and why that is not when they start

The peak arrives near the end of the transition, not at the beginning — which is the opposite of what the phrase "perimenopause symptoms" tends to suggest.

A meta-analysis of 10 studies and 35,445 participants found that the proportion of women reporting hot flashes and night sweats rose sharply in the two years before the final menstrual period, "peaked 1 year after final menstrual period," and did not return to premenopausal levels until about eight years after it (Politi et al., 2008). SWAN's longitudinal analysis of 3,198 women arrives at nearly the same place from the other side: the transition to late perimenopause — the stage immediately before the final period — showed by far the strongest association with vasomotor symptoms, at an adjusted odds ratio of 6.64 (95% CI 4.80–9.20), with symptoms reported "nearly as often in postmenopause" (Gold et al., 2006). Those two findings sit a few months apart rather than in conflict, and both point into the same window. Our guide to the stages covers where in the transition symptoms usually peak and how to tell which one you are in.

Politi adds a refinement worth carrying: when the data were split by severity, bothersome symptoms peaked about a year earlier than symptoms of any severity and declined faster (Politi et al., 2008). The hardest stretch, in other words, comes before the most crowded one.

You can turn all of that into an age, but only by doing arithmetic the sources do not do for you. A median final period of 51.4 to 52.54 (Gold 2001; Gold 2013) plus Politi's one-year lag lands somewhere around 52 to 53. That is our inference from two separate medians, not a figure any study cited here publishes — we found no source that reports a peak age directly, and we are not going to be the first to invent one.

What a median of 47 can and cannot tell you

Both onset figures carry the same limitation, and it is worth knowing before you measure yourself against them.

The Massachusetts cohort was assembled from women aged 45 to 55 as of 1 January 1982, and the onset analysis used the subset who were still premenopausal at that point (McKinlay et al., 1992). SWAN enrolled women aged 42 to 52 (Paramsothy et al., 2017). Neither study could observe a transition that began at 38, because women that age were not in the sample. So a median of 47 describes when perimenopause begins among women who reach their mid-40s without having started it — it is not a statement about the earliest age at which it can begin, and the lower tail of this distribution is genuinely less well measured than the middle.

SWAN also defined the start by cycles rather than by how anyone felt: "a persistent difference of at least 7 days in the length of consecutive menstrual cycles," with persistence meaning recurrence within 10 cycles (Paramsothy et al., 2017). That is a calendar measurement, not a symptom one, which turns out to matter more than any of the ages above.

Is there a "most common" age?

Not one that anybody publishes. "Most common" asks for a mode — the single age that occurs more often than any other — and none of the sources on this page reports one. What the literature contains is medians, which answer a different question: the age by which half the group had started. We looked for a modal figure in the NIA, the Office on Women's Health, ACOG, NHS inform, the Merck Manual, Cleveland Clinic and The Menopause Society, and in the five cohort analyses cited here, and found none in any of them. Where a page offers you a single most common age, it is worth asking where that number came from.

What each health authority actually says

The major sources agree on the middle of the range and differ at the edges, so here they are side by side rather than averaged into one number.

Read the columns together and the arithmetic mostly works: a median start near 47 and a median final period of 51 or 52 put most women's perimenopausal years between the late 40s and the early 50s, a gap of roughly four to five years.

One figure in that table does not fit, and it is worth saying so. Cleveland Clinic's "eight to 10 years before menopause" is about double the gap every other source on this page implies — including Cleveland Clinic's own page, which a few paragraphs later gives "the average length of perimenopause is about four years, but it can last up to eight years" (Cleveland Clinic). Those two statements cannot both describe the same interval, and we could not find the basis for the longer one. We have followed the cohort medians and the four-year figure, and left the discrepancy visible rather than quietly dropping the number that did not suit.

Cleveland Clinic's wider onset window — mid-30s to mid-50s — is a different matter, and not a contradiction at all. It is the tails of the same distribution, and real women live in them.

Worth keeping the two terms apart while reading that table, because they are routinely swapped: perimenopause is the transition, a span of years, while menopause is a single point in time — the final menstrual period, identifiable only 12 months afterwards. The average-age-of-menopause figure describes that point, not the start of the transition.

Why age is the wrong way to tell where you are

Age is what the transition correlates with. It is not what defines it. The clinical staging system for reproductive aging — the Stages of Reproductive Aging Workshop +10, or STRAW+10, which is what specialists use — stages women on menstrual criteria and hormone markers. There is no age anywhere in its criteria (Harlow et al., 2012).

That matters practically, because two of its criteria are things you can check against your own calendar without a clinic or a blood draw.

Criteria quoted from STRAW+10 (Harlow et al., 2012). The research version of the staging system also uses anti-Müllerian hormone and antral follicle counts; the menstrual criteria above are the ones a reader can apply herself.

Two things fall out of that table. The first is that a 38-year-old whose cycles have swung persistently by more than a week meets the same criterion as a 48-year-old whose cycles have done the same thing. The stage is defined by the pattern, not by which of them is "old enough" for it. The second is the last row: perimenopause does not end at your last period. STRAW+10 defines the term as beginning at Stage −2 and ending "12 months after the FMP" — so the entire first postmenopausal year sits inside it. Nearly every consumer page implies otherwise, and it changes both when the transition is over and how long you need contraception.

If you want the full definition and staging behind this, our guide to what perimenopause actually is covers the whole framework.

When perimenopause starts: the signals, not the birthday

Cycle length changes first, and it usually shortens before it lengthens. STRAW+10 describes the stage immediately before the transition as involving "subtle changes in menstrual cycle characteristics, specifically shorter cycles" (Harlow et al., 2012). Cycles that have quietly gone from 29 days to 26 are easy to miss, or to attribute to stress. The NIA reaches the same place from the other direction, listing changes in your period first among what you might notice and adding, "this might be what you notice first" (NIA).

So the useful record is not a symptom diary. It is cycle lengths — first day of bleeding to first day of the next — kept for a year or more, because the criteria compare consecutive cycles against each other. A paper calendar does this as well as anything.

There is one piece of foresight worth having early, because it is the opposite of what most people are told. If hot flashes and night sweats start before your cycles have visibly changed, that predicts a longer course, not a shorter one. In SWAN — the Study of Women's Health Across the Nation — 1,449 women with frequent vasomotor symptoms were followed, and those who were premenopausal or in early perimenopause when symptoms began had a median total duration of more than 11.8 years, against 3.4 years for women whose symptoms started only after menopause. The authors call onset stage "the best single predictor" of duration (Avis et al., 2015). Early onset is an argument for treating symptoms rather than waiting them out; our guide to what perimenopause symptoms actually look like sorts them by how much each one really tells you.

Starting early: perimenopause in your 30s and early 40s

Being told you are too young for this is common and it is not always right. Cleveland Clinic states plainly that perimenopause "may begin as early as your mid-30s" (Cleveland Clinic). The staging criteria above apply at 36 exactly as they do at 46.

What changes below 40 is not whether it can happen but what happens next. Two terms are worth knowing, because they are the ones a clinician will use:

• Early menopause. The definitions genuinely differ, and the gap is not academic if you are 44. NICE defines it as "menopause between the ages of 40 and 44" (NICE NG23). The NHS defines it as stopping regular periods "before the age of 45" (NHS). The Office on Women's Health gives both on one page: "Menopause that happens between 40 and 45 is called early menopause" near the top, and "Menopause that happens before age 45 is called early menopause" further down (OWH). We cannot reconcile those, and we are not going to pick one silently. What they agree on is the part that matters clinically — menopause in the early 40s warrants assessment rather than reassurance. OWH puts the frequency at "about 5% of women" (OWH).
• Premature menopause — menopause before 40, "which is also medically called primary ovarian insufficiency [POI]" (OWH). Cleveland Clinic uses the same two terms, noting that when there is no medical or surgical cause for premature menopause it is called primary ovarian insufficiency (Cleveland Clinic). The Menopause Society puts it at "about three in 100 women" (The Menopause Society).

This is also the one place in the whole topic where a blood test genuinely earns its keep. For most women over 45, hormone testing is not how the diagnosis is made: "hormone testing isn't necessary to diagnose perimenopause," Cleveland Clinic states, because "hormone levels fluctuate so much that the tests aren't reliable" (Cleveland Clinic). That is structural rather than logistical — STRAW+10 describes early-transition FSH as "elevated but variable" (Harlow et al., 2012), so a single draw can land anywhere. But the NIA notes that "in some cases, for example if a woman's periods stopped at an early age, a doctor may suggest a blood test to check hormone levels" (NIA), and the OWH says a provider assessing suspected early or premature menopause "may give you a blood test to measure estrogen and related hormones" (OWH). The same test that is close to useless at 48 is informative at 37.

NICE draws the line in the same place, and does it with ages rather than adjectives: use a serum FSH level to confirm menopause only "in people aged 40 to 45 with menopause-associated symptoms, including a change in their menstrual cycle" or "in people under 40 in whom menopause is suspected" (NICE NG23). For suspected premature ovarian insufficiency it asks for symptoms plus "elevated follicle stimulating hormone (FSH) levels on 2 blood samples taken 4 to 6 weeks apart," and says plainly: "Do not diagnose premature ovarian insufficiency on the basis of a single blood test" (NICE NG23). If you are under 40 and someone draws one tube and gives you an answer, that is not the standard.

The practical instruction is short: symptoms or a run of missed periods before 40 warrant an appointment rather than self-diagnosis. Early and premature menopause carry health consequences the OWH lists explicitly — a higher risk of serious problems "such as heart disease and osteoporosis, since women will live longer without the health benefits of higher estrogen levels" (OWH) — and those are manageable, but only once someone has actually looked.

Starting later, and what the evidence says about why

The upper tail is real too, and it is served worse than the lower one. Cleveland Clinic documents onset as late as the mid-50s, and the OWH gives the usual range for menopause itself as 45 to 58 (Cleveland Clinic; OWH). A woman of 55 still having irregular periods is inside a documented range, not outside one.

Two consequences follow, and both get skipped. The first: the 12-month clock is the only thing that settles it. Menopause "can't be confirmed until one year after a woman's final menstrual period" (NIA) — an age, however plausible, confirms nothing. The second follows from the first. The OWH states without qualification that "you can still get pregnant during perimenopause, the transition to menopause, even if you miss your period for a month or a few months," and the NIA advises continuing birth control for a full 12 months after the last period (OWH; NIA). Skipped periods at 54 are not contraception.

As for what shifts the timing, the honest list is shorter than the ones competitors publish. The NIA describes onset and symptoms as "likely influenced by a woman's genetics as well as external factors, such as race and ethnicity, culture, lifestyle, and environment," and names one specific association: smoking "is associated with an early onset of menopause and more severe menopausal symptoms" (NIA). The OWH puts a magnitude on that — smokers "may reach menopause as many as two years before nonsmokers" — and adds two more: never having had children, since "pregnancy, especially more than one pregnancy, may delay menopause," and a family history of early or premature menopause (OWH; OWH). Chemotherapy, pelvic radiation and surgical removal of both ovaries can also bring menopause forward, in the case of surgery immediately (OWH).

The two cohorts behind this page put numbers on the smoking association, and they agree on the order of magnitude. In the Massachusetts Women's Health Study the median age at natural menopause differed by 1.8 years between current smokers and non-smokers (McKinlay et al., 1992). In SWAN the gap at the start of the transition was about 1.2 years — adjusted medians of 46.05 for current smokers against 47.27 for non-smokers — and smokers also had a shorter transition once it began (Paramsothy et al., 2017). So roughly one to two years, earlier at both ends.

These are associations observed across populations, most of them not things anyone chooses — and none predicts an individual date.

Race, ethnicity, and a disagreement worth seeing

The differences here are documented and substantial, and they are usually left out of consumer pages entirely. They also do not all point the same way: the part of this that concerns age is actively contested, while the part that concerns duration is not.

The NIA states the age claim directly: "Compared with White women, Black women are more likely to have an early onset of menopause, experience more menopausal symptoms, and have symptoms for longer, while Asian women are less likely to suffer from menopausal symptoms" (NIA).

SWAN's longitudinal analysis does not support the onset half of that. Following 3,302 women from 1996 to 2007 to 1,483 observed natural final periods, it reported: "Controlling for sociodemographic, lifestyle, and health factors, we found that racial/ethnic groups did not differ in age at the FMP" (Gold et al., 2013). An earlier cross-sectional SWAN analysis of 14,620 women had found a difference running the other way — Japanese race/ethnicity was associated with a later age at natural menopause, after adjustment (Gold et al., 2001).

So a federal health agency says Black women reach menopause earlier, and the US cohort study most often cited for menopause timing says racial and ethnic groups do not differ in age at the final period once socioeconomic and lifestyle factors are controlled for. We are not going to resolve that, and the adjustment is exactly why: the null finding is conditional on controlling for education, employment, smoking, alcohol, physical activity and self-rated health, several of which are themselves patterned by race in the United States. Controlling for them answers a narrower question than the one most readers are asking. Knowing that the claim is contested is more useful than being handed whichever version reads more confidently.

Where the evidence does converge is on duration rather than onset. Among the 1,449 women SWAN followed with frequent hot flashes and night sweats, median total duration differed by race and ethnicity, with every pairwise difference statistically significant except Chinese versus Japanese (P < .05):

Avis et al., 2015, SWAN. Median total duration across the whole sample was 7.4 years. The transition itself also ran longer in African American than in white women in SWAN's menstrual-calendar substudy (Paramsothy et al., 2017).

More than five years separate the top and bottom rows. What we are not going to do is explain them, because we found no verified explanation to give. These are observed differences in large US cohorts, and the NIA's own framing groups genetics, race and ethnicity, culture, lifestyle and environment together as likely influences without separating out their contributions (NIA). Anything more confident than that would be invention.

The reason to publish it anyway is that expectations get set by an average that fits some women poorly. A Black woman told to expect a few years of symptoms is being given a figure the largest US longitudinal study of this question does not support for her.

How long it lasts once it starts

The transition can last "between two and eight years before your periods stop permanently" and runs about four years for most women (OWH), a figure Cleveland Clinic matches with the same four-year average and an upper bound of eight (Cleveland Clinic). Symptoms are a separate measurement with a longer answer — a median of 7.4 years for frequent vasomotor symptoms in SWAN, persisting a median of 4.5 years past the final period (Avis et al., 2015) — and because those two numbers get quoted interchangeably almost everywhere, how long the transition and its symptoms last is handled on its own page.

Common questions about perimenopause age (FAQ)

What is the most common age to start perimenopause? No source publishes a single most common age, and the pages that imply one are usually rounding a median. The two cohorts that measured onset directly put that median near 47: 47.5 years in the Massachusetts Women's Health Study (McKinlay et al., 1992), and adjusted medians of 47.27 years for non-smokers and 46.05 for current smokers in SWAN (Paramsothy et al., 2017). Agency guidance is vaguer and consistent with it — the mid- to late 40s (OWH), with most women beginning the transition between 45 and 55 (NIA).

At what age does perimenopause peak? Symptoms peak near the end of the transition rather than at its start. A meta-analysis of 10 studies and 35,445 participants found that the share of women reporting hot flashes and night sweats "peaked 1 year after final menstrual period" (Politi et al., 2008), and in SWAN the transition to late perimenopause carried the strongest association with those symptoms, at an adjusted odds ratio of 6.64 (95% CI 4.80–9.20) (Gold et al., 2006). Putting that one-year lag together with median final-period ages of 51.4 and 52.54 (Gold et al., 2001; Gold et al., 2013) gives a rough peak around 52 to 53 — but that last step is our arithmetic, not a figure any of these studies publishes.

Can perimenopause start at 35? Cleveland Clinic states that perimenopause may begin as early as the mid-30s, so yes (Cleveland Clinic). What differs below 40 is the follow-up rather than the symptoms. Menopause completed before 40 is premature menopause, "which is also medically called primary ovarian insufficiency [POI]" (OWH), and it is one of the few situations in which guidelines actively ask for hormone testing — NICE wants symptoms plus elevated FSH "on 2 blood samples taken 4 to 6 weeks apart," and warns against diagnosing it from a single test (NICE NG23). Symptoms or a run of missed periods before 40 are worth an appointment rather than an assumption.

Am I too old for perimenopause at 55? No. The Office on Women's Health gives the usual range for menopause itself as 45 to 58 (OWH), Cleveland Clinic documents perimenopause starting as late as the mid-50s (Cleveland Clinic), and The Menopause Society puts the proportion who have reached menopause by 55 at about 90% (The Menopause Society) — which leaves roughly one woman in ten who has not. Menopause cannot be confirmed until 12 months have passed without a period (NIA); until then you are still in the transition, and still able to become pregnant (OWH). New or unusual bleeding at this age still needs checking rather than attributing to the transition.

Does the age perimenopause starts run in families? Partly, though the sources are less precise than the question implies. The Office on Women's Health suggests that "one way to tell when you might go through menopause is the age your mother went through it," and separately states that women with a family history of early or premature menopause are more likely to experience it themselves (OWH; OWH). The NIA describes timing as likely influenced by genetics alongside race and ethnicity, culture, lifestyle and environment (NIA). Neither source gives a figure for how closely a mother's age predicts a daughter's, and we could not find one to cite.

Medical disclaimer: This article is for informational purposes only. Always consult a qualified healthcare provider before making changes to your health routine.

Sources

1. National Institute on Aging (NIH). What Is Menopause? — Government health information. https://www.nia.nih.gov/health/menopause/what-menopause
2. Office on Women's Health, US Department of Health and Human Services. Menopause basics — Government health information. https://womenshealth.gov/menopause/menopause-basics
3. Office on Women's Health, US Department of Health and Human Services. Early or premature menopause — Government health information. https://womenshealth.gov/menopause/early-or-premature-menopause
4. National Institute for Health and Care Excellence. Menopause: identification and management (NG23), Recommendations — National clinical guideline (England). https://www.nice.org.uk/guidance/ng23/chapter/Recommendations
5. NHS. Early or premature menopause — Government health information (UK). https://www.nhs.uk/conditions/early-or-premature-menopause/
6. NHS inform. Menopause — Government health information (Scotland). https://www.nhsinform.scot/healthy-living/womens-health/later-years-around-50-years-and-over/menopause-and-post-menopause-health/menopause/
7. American College of Obstetricians and Gynecologists. The Menopause Years (FAQ047) — Professional society patient information. https://www.acog.org/womens-health/faqs/the-menopause-years
8. The Menopause Society. Symptoms — Professional society patient information. https://menopause.org/patient-education/menopause-topics/symptoms
9. The Menopause Society. Premature Menopause — Professional society patient information. https://menopause.org/patient-education/menopause-topics/premature-menopause
10. Merck Manual Professional Edition. Menopause — Clinical reference. https://www.merckmanuals.com/professional/gynecology-and-obstetrics/menopause/menopause
11. Cleveland Clinic. Perimenopause — Health system disease reference. https://my.clevelandclinic.org/health/diseases/21608-perimenopause
12. McKinlay SM, Brambilla DJ, Posner JG. The normal menopause transition. Maturitas, 1992 Jan;14(2):103–15 — Peer-reviewed journal article (Massachusetts Women's Health Study). https://pubmed.ncbi.nlm.nih.gov/1565019/
13. Paramsothy P, Harlow SD, Nan B, et al. Duration of the menopausal transition is longer in women with young age at onset: the multiethnic Study of Women's Health Across the Nation. Menopause, 2017 Feb;24(2):142–149 — Peer-reviewed journal article (SWAN). https://pubmed.ncbi.nlm.nih.gov/27676632/
14. Gold EB, Bromberger J, Crawford S, et al. Factors associated with age at natural menopause in a multiethnic sample of midlife women. American Journal of Epidemiology, 2001 May 1;153(9):865–74 — Peer-reviewed journal article (SWAN, cross-sectional). https://pubmed.ncbi.nlm.nih.gov/11323317/
15. Gold EB, Crawford SL, Avis NE, et al. Factors related to age at natural menopause: longitudinal analyses from SWAN. American Journal of Epidemiology, 2013 Jul 1;178(1):70–83 — Peer-reviewed journal article (SWAN, longitudinal). https://pubmed.ncbi.nlm.nih.gov/23788671/
16. Politi MC, Schleinitz MD, Col NF. Revisiting the duration of vasomotor symptoms of menopause: a meta-analysis. Journal of General Internal Medicine, 2008 Sep;23(9):1507–13 — Peer-reviewed meta-analysis. https://pubmed.ncbi.nlm.nih.gov/18521690/
17. Gold EB, Colvin A, Avis N, et al. Longitudinal Analysis of the Association Between Vasomotor Symptoms and Race/Ethnicity Across the Menopausal Transition: Study of Women's Health Across the Nation. American Journal of Public Health, 2006 Jul;96(7):1226–1235 — Peer-reviewed journal article via PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC1483882/
18. Harlow SD, Gass M, Hall JE, et al. Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging. Menopause, 2012;19(4) — Peer-reviewed journal article via PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC3340903/
19. Avis NE, Crawford SL, Greendale G, et al. Duration of Menopausal Vasomotor Symptoms Over the Menopause Transition. JAMA Internal Medicine, 2015;175(4):531–539 (SWAN) — Peer-reviewed journal article via PMC. https://pmc.ncbi.nlm.nih.gov/articles/PMC4433164/

All sources accessed and re-verified 7 October 2026.

Claire Whitfield

Women's Health Specialist

A women's health specialist who thinks a population average is a poor substitute for a fact about you.

View profileView Xing profile